{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/urological-cancers-recognition-referral/management/referral-for-suspected-urological-cancer/","result":{"pageContext":{"chapter":{"id":"bcec9d33-8447-5aa1-8b94-9ed03208f8f7","slug":"referral-for-suspected-urological-cancer","fullItemName":"Scenario: Referral for suspected urological cancer","depth":2,"htmlHeader":"<!-- begin field 73d864c6-f08e-4508-869c-61d7b63b6b03 --><h2>Scenario: Referral for suspected urological cancer</h2><!-- end field 73d864c6-f08e-4508-869c-61d7b63b6b03 -->","summary":"Covers the referral of people with suspected urological cancer.","htmlStringContent":"<!-- begin item 8d9d42a5-97eb-49a9-b5cf-148bc56a5df7 --><!-- begin field 6e1adc58-7a36-480d-acd6-acd900acc300 --><p>From birth onwards.</p><!-- end field 6e1adc58-7a36-480d-acd6-acd900acc300 --><!-- end item 8d9d42a5-97eb-49a9-b5cf-148bc56a5df7 -->","topic":{"id":"c64ec72d-4714-555b-b12a-fd441ca67b32","topicId":"4ccc54cd-a2c6-4fd3-9483-7b55de4e06fa","topicName":"Urological cancers - recognition and referral","slug":"urological-cancers-recognition-referral","lastRevised":"Last revised in February 2021","chapters":[{"id":"a6bb987a-e632-5fc3-8d30-fb871a028ed1","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"748a62ad-5b04-5468-a5ce-97c6481c7566","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"18d46e59-36c7-5b55-aa65-3600c901940f","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"a4e597f1-cc63-5d3b-97b7-ed0c1cbb2b37","slug":"changes","fullItemName":"Changes"},{"id":"969bbc1b-89ab-597b-9c13-e58c73973c47","slug":"update","fullItemName":"Update"}]},{"id":"2b375e17-1588-5dbc-bd02-bb06db6b34ff","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"a969ea4e-5b1e-5ce3-bc10-facb662797f9","slug":"goals","fullItemName":"Goals"},{"id":"dd20c78a-fc7f-5f9c-a882-115907b19165","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"9561691a-2035-5b37-9e9e-4f2930856afa","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"39713e7a-6ade-5468-a916-ef42fb466e19","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"559f945f-9805-56d3-b5eb-907dd06c68ab","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f90e5ce7-fddd-5929-994b-81f3568808c0","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d68f575b-7060-52ac-8397-7dadfd612178","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"09cdbe97-79a1-5fd5-b0ef-8ca162bc3cba","slug":"presentation","fullItemName":"Presentation"},{"id":"0aebe8af-5f71-5805-b567-6d95c95ee05b","slug":"prevalence","fullItemName":"Prevalence"},{"id":"6141fbed-d327-5e18-970c-951c38a9bfab","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"f05bba22-10c0-58ff-9c5e-eb8128e76aa3","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"57be949e-d544-560a-b03e-2211a2434d97","slug":"symptoms-suggestive-of-urological-cancers","fullItemName":"Symptoms suggestive of urological cancers"}]},{"id":"3b871537-9b9d-5b6f-a750-e314b06f2660","fullItemName":"Management","slug":"management","subChapters":[{"id":"bcec9d33-8447-5aa1-8b94-9ed03208f8f7","slug":"referral-for-suspected-urological-cancer","fullItemName":"Scenario: Referral for suspected urological cancer"}]},{"id":"f07308a4-4a9f-55e5-8994-88375e0358ff","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"4ea550c2-d5c5-5e7c-86f1-51e4d7508e56","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"bf6e9a70-8a4c-5aa5-9951-1b82bb2b47f1","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0c4e1071-9827-57a2-bd0b-d69f2f249539","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"1974a788-5c91-5701-ad92-0ccfd3d277ff","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2fd10533-9dfe-597b-937c-9ab7aff2a1d8","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"5d9c3f4e-c903-581a-b904-6ff63017d472","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"c6ee8bcb-de73-5436-b699-cc8bb3dbaee2","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"3b871537-9b9d-5b6f-a750-e314b06f2660","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"e71c45e0-b480-5db2-b1b0-7acb8ab80a42","slug":"referral-timelines","fullItemName":"Referral timelines","depth":3,"htmlHeader":"<!-- begin field 52cce6cc-0456-413f-8cf9-b17c807c44c9 --><h3>Referral timelines</h3><!-- end field 52cce6cc-0456-413f-8cf9-b17c807c44c9 -->","summary":null,"htmlStringContent":"<!-- begin item 81b2800d-fd2d-403a-bca8-ca0839c8980b --><!-- begin field 99b33480-ba62-4f2f-9f8d-0b9a3517d702 --><ul><li>The terms used in the National Institute for Health and Care Excellence (NICE) guideline <em>Suspected cancer: recognition and referral</em> are as follows:<br><ul><li>Immediate: an acute admission or referral occurring within a few hours, or even more quickly if necessary.</li><li>Urgent: to happen/be performed within 2 weeks.</li><li>Very urgent: to happen within 48 hours.</li><li>Non-urgent: the timescale generally used for a referral or investigation that is not considered very urgent or urgent.</li><li>Suspected cancer pathway referral: the patient is seen within the national target for cancer referrals. </li></ul></li></ul><!-- end field 99b33480-ba62-4f2f-9f8d-0b9a3517d702 --><!-- end item 81b2800d-fd2d-403a-bca8-ca0839c8980b -->","subChapters":[{"id":"b583ed28-5bb8-543b-b28e-e0f223c9a178","slug":"basis-for-recommendation-02f","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 9a066280-2790-4367-be66-dac55d362268 --><h4>Basis for recommendation</h4><!-- end field 9a066280-2790-4367-be66-dac55d362268 -->","summary":null,"htmlStringContent":"<!-- begin item 02f190ff-87c9-4c17-bd53-bc8ff31cad8c --><!-- begin field 76802a56-7bc0-4a17-89ab-30e7ce121f5c --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 76802a56-7bc0-4a17-89ab-30e7ce121f5c --><!-- end item 02f190ff-87c9-4c17-bd53-bc8ff31cad8c -->","subChapters":[]}]},{"id":"52843cce-2596-5c61-80e2-0b733290e2a9","slug":"referral-for-suspected-prostate-cancer","fullItemName":"Referral for suspected prostate cancer","depth":3,"htmlHeader":"<!-- begin field 0ac87377-4052-4941-b617-3cadebe26f06 --><h3>Referral for suspected prostate cancer</h3><!-- end field 0ac87377-4052-4941-b617-3cadebe26f06 -->","summary":null,"htmlStringContent":"<!-- begin item 54ffb46a-5f53-43f6-8a49-b944a55026a7 --><!-- begin field da00e680-25da-4428-9b23-698d9328c569 --><ul><li><strong>Refer men using a suspected cancer pathway referral (for an appointment within 2 weeks) for prostate cancer if their prostate feels malignant on digital rectal examination.</strong></li><li>Consider a prostate-specific antigen (PSA) test and digital rectal examination to assess for prostate cancer in men with:<ul><li>Any lower urinary tract symptoms, such as nocturia, urinary frequency, hesitancy, urgency or retention, or</li><li>Erectile dysfunction, or</li><li>Visible haematuria.</li></ul></li><li><strong>Refer men using a suspected cancer pathway referral (for an appointment within 2 weeks) for prostate cancer if their PSA levels are above the age-specific reference range.</strong></li></ul><!-- end field da00e680-25da-4428-9b23-698d9328c569 --><!-- end item 54ffb46a-5f53-43f6-8a49-b944a55026a7 -->","subChapters":[{"id":"24f8db69-3127-5281-b5f0-548986b7a1c0","slug":"basis-for-recommendation-b92","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field a604ccef-1ffd-4f9e-aa00-02671209c986 --><h4>Basis for recommendation</h4><!-- end field a604ccef-1ffd-4f9e-aa00-02671209c986 -->","summary":null,"htmlStringContent":"<!-- begin item b92e7afb-f97b-4f58-9a72-841dc8566d04 --><!-- begin field be2d7065-05fb-483a-aa59-14b08817a1ea --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field be2d7065-05fb-483a-aa59-14b08817a1ea --><!-- end item b92e7afb-f97b-4f58-9a72-841dc8566d04 -->","subChapters":[]}]},{"id":"e2d971d1-49b7-59a1-8b57-842630ca51ac","slug":"referral-for-suspected-bladder-cancer","fullItemName":"Referral for suspected bladder cancer","depth":3,"htmlHeader":"<!-- begin field 3085a66f-2b5b-4060-9f23-cf82219233a9 --><h3>Referral for suspected bladder cancer</h3><!-- end field 3085a66f-2b5b-4060-9f23-cf82219233a9 -->","summary":null,"htmlStringContent":"<!-- begin item e598c8eb-2e2e-4b45-bda4-0434c4534a17 --><!-- begin field ec17c335-480f-46d2-878d-1cf2851f8723 --><ul><li><strong>Refer people using a suspected cancer pathway referral (for an appointment within 2 weeks) for bladder cancer if they are:</strong><ul><li>Aged 45 years and over and have:<ul><li>Unexplained visible haematuria without urinary tract infection, or</li><li>Visible haematuria that persists or recurs after successful treatment of urinary tract infection, or</li></ul></li><li>Aged 60 years and over and have unexplained non-visible haematuria and either dysuria or a raised white cell count on a blood test.</li></ul></li><li><strong>Consider non-urgent referral for bladder cancer in people aged 60 years and over with recurrent or persistent unexplained urinary tract infection.</strong></li></ul><!-- end field ec17c335-480f-46d2-878d-1cf2851f8723 --><!-- end item e598c8eb-2e2e-4b45-bda4-0434c4534a17 -->","subChapters":[{"id":"91932158-5492-56c5-b7b4-fffadc013a8b","slug":"basis-for-recommendation-442","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field be36d86a-80dc-4fb7-92b9-a408685c94d5 --><h4>Basis for recommendation</h4><!-- end field be36d86a-80dc-4fb7-92b9-a408685c94d5 -->","summary":null,"htmlStringContent":"<!-- begin item 442e0203-2d06-4635-bf81-bd5ba066cf5e --><!-- begin field 999dff80-3149-4572-9af0-af77adb9f03d --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 999dff80-3149-4572-9af0-af77adb9f03d --><!-- end item 442e0203-2d06-4635-bf81-bd5ba066cf5e -->","subChapters":[]}]},{"id":"10ef7e47-613c-5339-8300-f126672a7d63","slug":"referral-for-suspected-renal-cancer","fullItemName":"Referral for suspected renal cancer","depth":3,"htmlHeader":"<!-- begin field 07ddfc25-a4e3-46e3-996a-311c48a15455 --><h3>Referral for suspected renal cancer</h3><!-- end field 07ddfc25-a4e3-46e3-996a-311c48a15455 -->","summary":null,"htmlStringContent":"<!-- begin item 6371969c-bd42-4794-b108-5efa5df64c9f --><!-- begin field fa3e3738-45c5-433c-97a1-eadae174ce75 --><ul><li><strong>Refer people using a suspected cancer pathway referral (for an appointment within 2 weeks) for renal cancer if they are aged 45 years and over and have:</strong><ul><li>Unexplained visible haematuria without urinary tract infection, or</li><li>Visible haematuria that persists or recurs after successful treatment of urinary tract infection.</li></ul></li></ul><!-- end field fa3e3738-45c5-433c-97a1-eadae174ce75 --><!-- end item 6371969c-bd42-4794-b108-5efa5df64c9f -->","subChapters":[{"id":"21653496-6947-5c7e-b5a6-23f8d2afecdf","slug":"basis-for-recommendation-c5c","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field ecea1cef-f064-4a7d-9e7e-3c0cd7c6ea1a --><h4>Basis for recommendation</h4><!-- end field ecea1cef-f064-4a7d-9e7e-3c0cd7c6ea1a -->","summary":null,"htmlStringContent":"<!-- begin item c5c8215c-e095-40ec-ad90-e8b30a4d6cff --><!-- begin field c3fc77cb-afab-431f-8b72-55310fe4e90e --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field c3fc77cb-afab-431f-8b72-55310fe4e90e --><!-- end item c5c8215c-e095-40ec-ad90-e8b30a4d6cff -->","subChapters":[]}]},{"id":"236177d3-0f6f-5945-b200-8506907c0ced","slug":"referral-for-suspected-testicular-cancer","fullItemName":"Referral for suspected testicular cancer","depth":3,"htmlHeader":"<!-- begin field 8644ca8d-dbe6-44da-8761-3446584444ae --><h3>Referral for suspected testicular cancer</h3><!-- end field 8644ca8d-dbe6-44da-8761-3446584444ae -->","summary":null,"htmlStringContent":"<!-- begin item 4dd471c4-726d-4567-b80f-caf9418bbdb2 --><!-- begin field 9689ea0f-465f-4517-a8ee-6a5329c6db8b --><ul><li><strong>Consider a suspected cancer pathway referral (for an appointment within 2 weeks) for testicular cancer in men if they have a non-painful enlargement or change in shape or texture of the testis.</strong></li><li><strong>Consider a direct access ultrasound scan for testicular cancer in men with unexplained or persistent testicular symptoms.</strong></li></ul><!-- end field 9689ea0f-465f-4517-a8ee-6a5329c6db8b --><!-- end item 4dd471c4-726d-4567-b80f-caf9418bbdb2 -->","subChapters":[{"id":"d574a614-b40b-5615-b494-dfc0242aadd4","slug":"basis-for-recommendation-77a","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 1f65ca2c-8418-47a1-b791-a21353040e6b --><h4>Basis for recommendation</h4><!-- end field 1f65ca2c-8418-47a1-b791-a21353040e6b -->","summary":null,"htmlStringContent":"<!-- begin item 77a006f2-cb66-48b1-bd87-ede330073568 --><!-- begin field 2e668fe8-a91a-49ac-95a0-400cf2ca61d6 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 2e668fe8-a91a-49ac-95a0-400cf2ca61d6 --><!-- end item 77a006f2-cb66-48b1-bd87-ede330073568 -->","subChapters":[]}]},{"id":"46ca5f5d-875c-58a8-8834-12bf123e997a","slug":"referral-for-suspected-penile-cancer","fullItemName":"Referral for suspected penile cancer","depth":3,"htmlHeader":"<!-- begin field 78d4f7f6-3080-4b68-87c5-8ae65904154a --><h3>Referral for suspected penile cancer</h3><!-- end field 78d4f7f6-3080-4b68-87c5-8ae65904154a -->","summary":null,"htmlStringContent":"<!-- begin item b095bc2b-ab8e-4f43-9c8f-6247142419b2 --><!-- begin field 2e64bb75-bf4a-4c06-b140-9bb3955c8601 --><ul><li><strong>Consider a suspected cancer pathway referral (for an appointment within 2 weeks) for penile cancer in men if they have either:</strong><ul><li>A penile mass or ulcerated lesion, where a sexually transmitted infection has been excluded as a cause, or</li><li>A persistent penile lesion after treatment for a sexually transmitted infection has been completed.</li></ul></li><li><strong>Consider a suspected cancer pathway referral (for an appointment within 2 weeks) for penile cancer in men with unexplained or persistent symptoms affecting the foreskin or glans.</strong></li></ul><!-- end field 2e64bb75-bf4a-4c06-b140-9bb3955c8601 --><!-- end item b095bc2b-ab8e-4f43-9c8f-6247142419b2 -->","subChapters":[{"id":"14d879c7-a65a-59c1-b48c-e66bdf883f42","slug":"basis-for-recommendation-495","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 1e342ed6-03e6-4b63-9e8a-d5f298309c25 --><h4>Basis for recommendation</h4><!-- end field 1e342ed6-03e6-4b63-9e8a-d5f298309c25 -->","summary":null,"htmlStringContent":"<!-- begin item 495c6169-e7e6-4c6f-bf1e-1108d41a5315 --><!-- begin field a0e5b829-31d2-43b3-a26e-11e74e6fd069 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field a0e5b829-31d2-43b3-a26e-11e74e6fd069 --><!-- end item 495c6169-e7e6-4c6f-bf1e-1108d41a5315 -->","subChapters":[]}]},{"id":"fd515ce6-4c7b-5173-bf1d-5c368908da37","slug":"diagnostic-referral-process","fullItemName":"Diagnostic and referral process","depth":3,"htmlHeader":"<!-- begin field 07466fff-fd1f-4416-951d-1c4b30e4b08e --><h3>Diagnostic and referral process</h3><!-- end field 07466fff-fd1f-4416-951d-1c4b30e4b08e -->","summary":null,"htmlStringContent":"<!-- begin item b3d510e8-4558-4bdd-a188-93efc6b3c209 --><!-- begin field 19fb8316-ab5a-492d-9f2d-64022160ec87 --><ul><li>Discussion with a specialist (for example, by telephone or email) should be considered if there is uncertainty about the interpretation of symptoms and signs, and whether a referral is needed. This may also enable the primary healthcare professional to communicate their concerns and a sense of urgency to secondary healthcare professionals when symptoms are not classical.</li><li>Put in place local arrangements to ensure that letters about non-urgent referrals are assessed by the specialist, so that the person can be seen more urgently if necessary.</li><li>Put in place local arrangements to ensure that there is a maximum waiting period for non-urgent referrals, in accordance with national targets and local arrangements.</li><li>Ensure local arrangements are in place to identify people who miss their appointments so that they can be followed up.</li><li>Include all appropriate information in referral correspondence, including whether the referral is urgent or non-urgent.</li><li>Use local referral proformas if these are in use.</li><li>Once the decision to refer has been made, make sure that the referral is made within 1 working day.</li><li>Take part in continuing education, peer review, and other activities to improve and maintain clinical consulting, reasoning, and diagnostic skills, in order to identify at an early stage people who may have cancer, and to communicate the possibility of cancer to the person.</li></ul><!-- end field 19fb8316-ab5a-492d-9f2d-64022160ec87 --><!-- end item b3d510e8-4558-4bdd-a188-93efc6b3c209 -->","subChapters":[{"id":"79c68469-8c0c-5a44-baba-cbb4463c6d4c","slug":"basis-for-recommendation-b43","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field ccb3c20c-f080-44f7-bb1f-1d48c652260f --><h4>Basis for recommendation</h4><!-- end field ccb3c20c-f080-44f7-bb1f-1d48c652260f -->","summary":null,"htmlStringContent":"<!-- begin item b4345953-056f-41cc-9651-1c1a49121ef8 --><!-- begin field c6a0f503-4dbf-4c76-a493-dcafd0726a43 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field c6a0f503-4dbf-4c76-a493-dcafd0726a43 --><!-- end item b4345953-056f-41cc-9651-1c1a49121ef8 -->","subChapters":[]}]},{"id":"5ca9fb7a-2906-5449-be6d-2772ac0f786f","slug":"patient-information-support","fullItemName":"Patient information and support","depth":3,"htmlHeader":"<!-- begin field 431d736f-9475-4308-8d0d-9787f61ea0be --><h3>Patient information and support</h3><!-- end field 431d736f-9475-4308-8d0d-9787f61ea0be -->","summary":null,"htmlStringContent":"<!-- begin item 1e968588-7225-4320-873f-eff9acc220cc --><!-- begin field 4bbe5995-645c-4c63-afe7-9170d83f809b --><ul><li>Discuss with people with suspected cancer (and their carers as appropriate, taking account of the need for confidentiality) their preferences for being involved in decision-making about referral options and further investigations including their potential risks and benefits.</li><li>Explain to people who are being referred with suspected cancer that they are being referred to a cancer service. Reassure them, as appropriate, that most people referred will not have a diagnosis of cancer, and discuss alternative diagnoses with them.</li><li>Give the person information on the possible diagnosis (both benign and malignant) in accordance with their wishes for information.</li><li>The information given to people with suspected cancer and their families and/or carers should cover, among other issues:<ul><li>Where the person is being referred to.</li><li>How long they will have to wait for the appointment.</li><li>How to obtain further information about the type of cancer suspected or help before the specialist appointment.</li><li>What to expect from the service the person will be attending.</li><li>What type of tests may be carried out, and what will happen during diagnostic procedures.</li><li>How long it will take to get a diagnosis or test results.</li><li>Whether they can take someone with them to the appointment.</li><li>Who to contact if they do not receive confirmation of an appointment.</li><li>Other sources of support.</li></ul></li><li>Provide information that is appropriate for the person in terms of language, ability, and culture, recognizing the potential for different cultural meanings associated with the possibility of cancer.</li><li>Have information available in a variety of formats on both local and national sources of information and support for people who are being referred with suspected cancer.</li><li>When referring a person with suspected cancer to a specialist service, assess their need for continuing support while waiting for their referral appointment. This should include inviting the person to contact their healthcare professional again if they have more concerns or questions before they see a specialist.</li><li>If the person has additional support needs because of their personal circumstances, inform the specialist (with the person's agreement).</li><li>When cancer is suspected in a child, discuss the referral decision and information to be given to the child with the parents or carers (and the child if appropriate).</li></ul><!-- end field 4bbe5995-645c-4c63-afe7-9170d83f809b --><!-- end item 1e968588-7225-4320-873f-eff9acc220cc -->","subChapters":[{"id":"de5dd61d-9bd9-5168-b6b5-26349f36e6e9","slug":"basis-for-recommendation-d9c","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field a838a0ae-0cb5-4c76-b029-34f45701d3df --><h4>Basis for recommendation</h4><!-- end field a838a0ae-0cb5-4c76-b029-34f45701d3df -->","summary":null,"htmlStringContent":"<!-- begin item d9c13dde-4e64-4acc-8e91-91374768a30b --><!-- begin field 53b33ded-d884-4158-a168-2ec5419470a3 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 53b33ded-d884-4158-a168-2ec5419470a3 --><!-- end item d9c13dde-4e64-4acc-8e91-91374768a30b -->","subChapters":[]}]},{"id":"45850d15-4d35-5381-a655-67f8d50b83eb","slug":"safety-netting","fullItemName":"Safety netting","depth":3,"htmlHeader":"<!-- begin field a2fcf580-ef18-4af6-9286-d33131d6a649 --><h3>Safety netting</h3><!-- end field a2fcf580-ef18-4af6-9286-d33131d6a649 -->","summary":null,"htmlStringContent":"<!-- begin item 450cb361-674b-491b-9a1e-8f68a8b67dd0 --><!-- begin field 9f3056fb-2518-41d1-9c12-e7f5b77422b8 --><ul><li>Safety netting involves active monitoring of low risk people presenting with symptoms in primary care.</li><li>Explain to people who are being offered safety netting which symptoms to look out for and when they should return for re-evaluation. It may be appropriate to provide written information.</li><li>Reassure people in the safety netting group who are concerned that they may have cancer that with their current symptoms their risk of having cancer is low.</li><li>Ensure that the results of investigations are reviewed and acted upon appropriately, with the healthcare professional who ordered the investigation taking or explicitly passing on responsibility for this. Be aware of the possibility of false-negative results for chest X-rays and tests for occult blood in faeces.</li><li>Consider a review for people with any symptom that is associated with an increased risk of cancer, but who do not meet the criteria for referral or other investigative action. The review may be planned within a time frame agreed with the person or patient-initiated if new symptoms develop, the person continues to be concerned, or their symptoms recur, persist, or worsen.</li></ul><!-- end field 9f3056fb-2518-41d1-9c12-e7f5b77422b8 --><!-- end item 450cb361-674b-491b-9a1e-8f68a8b67dd0 -->","subChapters":[{"id":"1524b72e-2dfb-54ac-995a-a7c420da74ab","slug":"basis-for-recommendation-1d8","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 9334dba1-8dc8-4778-913a-351404514632 --><h4>Basis for recommendation</h4><!-- end field 9334dba1-8dc8-4778-913a-351404514632 -->","summary":null,"htmlStringContent":"<!-- begin item 1d842ded-425e-4b1d-a8c0-7e5f824fac3b --><!-- begin field 51be87e1-c440-4d32-a265-ce8fbf0da02d --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 51be87e1-c440-4d32-a265-ce8fbf0da02d --><!-- end item 1d842ded-425e-4b1d-a8c0-7e5f824fac3b -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}